Intrathecal baclofen (ITB) therapy is an established treatment for severe refractory spasticity. Although a positive ITB ...
Aurie has announced that the Aurie Reusable No-Touch Intermittent Catheter System has been granted marketing authorization from the U.S. Food and Drug Administration (FDA) through the Class II De Novo ...
Background Stroke remains one of the most serious complications of transcatheter aortic valve implantation (TAVI). This study ...
[Image from Aurie] Aurie announced today that it received FDA de novo clearance for its Aurie Reusable No-Touch Intermittent Catheter System. The Syracuse, New York-based company says the milestone ...
Fasting isn’t new, but that hasn’t stopped intermittent fasting (IF) from becoming one of the decade’s most popular diet trends. IF (often used interchangeably with the terms “time-restricted feeding” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results